Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Stopped Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in Japan. h

Conditions

• Pancreatic Cancer

Interventions

• DRUG: Gemcitabine
• DRUG: S-1

Sponsor

Hokkaido Gastrointestinal Cancer Study Group

Collaborators

• [object Object]